MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jgar.2025.11.001

Медицинская библиотека · Journal of global antimicrobial resistance · 2025

The resistance trends in Mycobacterium kansasii pulmonary isolates and identification of risk factors for drug resistance in Taiwan.

Fan Sheng-Bin, Huang Hung-Ling, Tu Hung-Pin, Sobkowiak Benjamin, Cheng Meng-Hsuan, Huang Wei-Chang, Huang Yi-Wen, Lin Shang-Yi, Chong Inn-Wen, Lu Po-Liang

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

Mycobacterium kansasii (M. kansasii) pulmonary disease is an emerging global health concern, and the pathogen's resistance to antimicrobial agents is challenging. Understanding the epidemiology of drug resistance rates and the associated risk factors is useful for guiding antimicrobial agent selection for M. kansasii treatment.

METHODS

This retrospective cohort study analysed 361 pathogenic M. kansasii isolates collected from patients with M. kansasii pulmonary disease in two tertiary medical centres in Taiwan between 2011 and 2022. Antimicrobial susceptibility testing was performed using Sensititre™ SLOMYCO1 or SLOMYCO2, and MIC breakpoints were according to CLSI 2018. We applied multivariate logistic regression and Cochran-Mantel-Haenszel test to assess the factors associated with drug resistance.

RESULTS

Most M. kansasii isolates in Taiwan remained susceptible to the first-line agents, including rifampin (92.2%) and clarithromycin (98.6%). High resistance rates were observed in ciprofloxacin (42.7%), doxycycline (56.2%), and trimethoprim/sulfamethoxazole (87.8%). The drug resistance rates of tested antibiotics for M. kansasii increased notably in 2018-2022 compared to those between 2015-2017. M. kansasii isolates from central Taiwan exhibited significantly higher resistance rates in all drugs compared to those in southern Taiwan. Pulmonary fibrocavitary lesion was an independent risk factor for resistance to rifampin and ciprofloxacin.

CONCLUSIONS

The study reveals increasing resistance to the first- and second-line agents in M. kansasii isolates across Taiwan. Resistance epidemiology differed between regions. Fibrocavitary lung lesion was significantly associated with drug resistance. These findings underscore the importance of region-specific surveillance to undergo individualized treatment strategies for M. kansasii pulmonary disease.

Для цитирования: Fan Sheng-Bin, Huang Hung-Ling, Tu Hung-Pin, Sobkowiak Benjamin, Cheng Meng-Hsuan, Huang Wei-Chang, Huang Yi-Wen, Lin Shang-Yi, Chong Inn-Wen, Lu Po-Liang. The resistance trends in Mycobacterium kansasii pulmonary isolates and identification of risk factors for drug resistance in Taiwan.. Journal of global antimicrobial resistance. 2025. DOI: 10.1016/j.jgar.2025.11.001.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.